Chou-Zheng, L., & Hatoum-Aslan, A. (2019). A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity. eLife.
Chicago Style CitationChou-Zheng, Lucy, i Asma Hatoum-Aslan. "A Type III-A CRISPR-Cas System Employs Degradosome Nucleases to Ensure Robust Immunity." ELife 2019.
Cita MLAChou-Zheng, Lucy, i Asma Hatoum-Aslan. "A Type III-A CRISPR-Cas System Employs Degradosome Nucleases to Ensure Robust Immunity." ELife 2019.
Atenció: Aquestes cites poden no estar 100% correctes.